Zanamivir
| Use attributes for filter ! | |
| Molar mass | 332. 31 g/mol |
|---|---|
| CAS ID | 139110-80-8 |
| Formula | C12H20N4O7 |
| Trade name | Relenza |
| Other names | 5-acetamido- 4-guanidino- 6-(1,2,3-trihydroxypropyl)- 5,6-dihydro- 4H-pyran- 2-carboxylic acid |
| Metabolism | Negligible |
| Music groups | Oseltamivir |
| Laninamivir | |
| Peramivir | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2922080 |
About Zanamivir
Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It is a neuraminidase inhibitor and was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza.